Researchers discovered that serotonin may exacerbate tinnitus by activating a specific neural circuit linked to ringing in the ears [1].
The findings provide a potential biological explanation for why some patients report louder tinnitus while taking selective serotonin reuptake inhibitors (SSRIs), which increase serotonin levels in the brain [1].
To reach these conclusions, scientists studied laboratory mice using optogenetics, a technique that employs light-based brain stimulation to control specific neurons [1, 2]. The team identified a serotonin-driven neural circuit that, when activated, produced tinnitus-like behavior in the animals [1, 2].
Serotonin is widely known as a "feel-good" chemical due to its role in regulating mood and happiness. However, this research suggests the chemical has a more complex role in the auditory system, one that can inadvertently fuel the perception of phantom sounds [2].
By isolating the specific pathway responsible for this reaction, the researchers have mapped how a chemical intended to stabilize mood can simultaneously intensify the distress caused by tinnitus [1]. This discovery highlights the intricate balance of brain chemistry and how a single neurotransmitter can produce vastly different effects across different neural circuits [2].
“Serotonin may exacerbate tinnitus by activating a specific neural circuit.”
This research suggests a pharmacological trade-off for patients treating depression or anxiety with SSRIs. While these medications improve mood by boosting serotonin, the activation of this specific neural circuit may increase the severity of tinnitus. This discovery could eventually lead to the development of targeted therapies that block the tinnitus-linked circuit without interfering with the mood-stabilizing benefits of serotonin.
